Guggenhime Andrew insider trades
Guggenhime Andrew has filed 56 Form 4s with the SEC that we hold, for Vaxcyte, Inc. (PCVX) (PRESIDENT AND CFO), Caribou Biosciences, Inc. (CRBU) (Director) and MTCR (Director). Across all of them we count 0 purchases worth $0 and 68 sales worth $18.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($1.6M). The largest single trade was a sale of 36,114 shares of Vaxcyte, Inc. worth $4.2M, dated 2024-10-18. The first filing on our record is dated 2021-11-22 and the latest 2026-09-09.
Vaxcyte, Inc. (PCVX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-18 | S, sale reported on Form 4 | 115 | $2.9K | 2021-11-22 |
| 2021-11-18 | S, sale reported on Form 4 | 2,985 | $73.1K | 2021-11-22 |
| 2021-12-23 | S, sale reported on Form 4 | 3,100 | $74.4K | 2021-12-28 |
| 2022-03-01 | S, sale reported on Form 4 | 6,200 | $148.8K | 2022-03-03 |
| 2022-03-18 | S, sale reported on Form 4 | 3,100 | $81.0K | 2022-03-22 |
| 2022-04-18 | S, sale reported on Form 4 | 3,100 | $74.6K | 2022-04-20 |
| 2022-05-18 | S, sale reported on Form 4 | 580 | $14.6K | 2022-05-20 |
| 2022-05-18 | S, sale reported on Form 4 | 2,520 | $61.1K | 2022-05-20 |
| 2022-07-08 | S, sale reported on Form 4 | 3,100 | $74.4K | 2022-07-12 |
| 2022-07-18 | S, sale reported on Form 4 | 9 | $225 | 2022-07-20 |
| 2022-07-18 | S, sale reported on Form 4 | 3,091 | $75.8K | 2022-07-20 |
| 2022-08-18 | S, sale reported on Form 4 | 2,551 | $64.1K | 2022-08-22 |
| 2022-08-18 | S, sale reported on Form 4 | 549 | $14.2K | 2022-08-22 |
| 2022-08-25 | S, sale reported on Form 4 | 17,052 | $477.5K | 2022-08-29 |
| 2022-08-26 | S, sale reported on Form 4 | 1,295 | $36.3K | 2022-08-29 |
| 2022-08-29 | S, sale reported on Form 4 | 17,653 | $494.3K | 2022-08-29 |
| 2022-09-19 | S, sale reported on Form 4 | 2,623 | $68.3K | 2022-09-21 |
| 2022-09-19 | S, sale reported on Form 4 | 477 | $12.7K | 2022-09-21 |
| 2023-10-18 | S, sale reported on Form 4 | 7,497 | $344.0K | 2023-10-20 |
| 2023-10-18 | S, sale reported on Form 4 | 503 | $23.3K | 2023-10-20 |
| 2023-11-20 | S, sale reported on Form 4 | 124 | $6.4K | 2023-11-22 |
| 2023-11-20 | S, sale reported on Form 4 | 7,876 | $402.6K | 2023-11-22 |
| 2023-12-14 | S, sale reported on Form 4 | 14,000 | $843.1K | 2023-12-18 |
| 2023-12-18 | S, sale reported on Form 4 | 117 | $7.1K | 2023-12-20 |
| 2023-12-18 | S, sale reported on Form 4 | 7,883 | $474.3K | 2023-12-20 |
| 2024-01-18 | S, sale reported on Form 4 | 4,387 | $264.4K | 2024-01-19 |
| 2024-01-18 | S, sale reported on Form 4 | 463 | $28.7K | 2024-01-19 |
| 2024-01-18 | S, sale reported on Form 4 | 23 | $1.5K | 2024-01-19 |
| 2024-01-18 | S, sale reported on Form 4 | 3,127 | $191.3K | 2024-01-19 |
| 2024-02-20 | S, sale reported on Form 4 | 4,909 | $363.7K | 2024-02-22 |
| 2024-02-20 | S, sale reported on Form 4 | 340 | $25.8K | 2024-02-22 |
| 2024-02-20 | S, sale reported on Form 4 | 2,751 | $206.8K | 2024-02-22 |
| 2024-03-18 | S, sale reported on Form 4 | 7,764 | $535.7K | 2024-03-20 |
| 2024-03-18 | S, sale reported on Form 4 | 236 | $16.4K | 2024-03-20 |
| 2024-04-18 | S, sale reported on Form 4 | 7,624 | $466.9K | 2024-04-22 |
| 2024-04-18 | S, sale reported on Form 4 | 376 | $23.3K | 2024-04-22 |
| 2024-05-20 | S, sale reported on Form 4 | 4,456 | $336.2K | 2024-05-22 |
| 2024-05-20 | S, sale reported on Form 4 | 3,544 | $263.7K | 2024-05-22 |
| 2024-06-18 | S, sale reported on Form 4 | 7,652 | $550.1K | 2024-06-20 |
| 2024-06-18 | S, sale reported on Form 4 | 348 | $25.3K | 2024-06-20 |
| 2024-07-18 | S, sale reported on Form 4 | 3,095 | $248.0K | 2024-07-22 |
| 2024-07-18 | S, sale reported on Form 4 | 926 | $77.0K | 2024-07-22 |
| 2024-07-18 | S, sale reported on Form 4 | 1,479 | $121.8K | 2024-07-22 |
| 2024-07-18 | S, sale reported on Form 4 | 2,500 | $202.7K | 2024-07-22 |
| 2024-08-19 | S, sale reported on Form 4 | 3,006 | $237.9K | 2024-08-20 |
| 2024-08-19 | S, sale reported on Form 4 | 4,994 | $390.8K | 2024-08-20 |
| 2024-09-18 | S, sale reported on Form 4 | 1,686 | $196.1K | 2024-09-19 |
| 2024-09-18 | S, sale reported on Form 4 | 5,485 | $634.1K | 2024-09-19 |
| 2024-09-18 | S, sale reported on Form 4 | 829 | $97.4K | 2024-09-19 |
| 2024-10-18 | S, sale reported on Form 4 | 5,886 | $683.9K | 2024-10-22 |
| 2024-10-18 | S, sale reported on Form 4 | 36,114 | $4.2M | 2024-10-22 |
| 2024-11-18 | S, sale reported on Form 4 | 6,111 | $523.1K | 2024-11-19 |
| 2024-11-18 | S, sale reported on Form 4 | 1,757 | $152.0K | 2024-11-19 |
| 2024-11-18 | S, sale reported on Form 4 | 132 | $11.5K | 2024-11-19 |
| 2024-12-18 | S, sale reported on Form 4 | 1,190 | $103.8K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 3,373 | $299.2K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 280 | $25.3K | 2024-12-19 |
| 2024-12-18 | S, sale reported on Form 4 | 3,157 | $282.0K | 2024-12-19 |
| 2025-01-21 | S, sale reported on Form 4 | 5,318 | $457.8K | 2025-01-22 |
| 2025-01-21 | S, sale reported on Form 4 | 1,999 | $174.4K | 2025-01-22 |
| 2025-01-21 | S, sale reported on Form 4 | 683 | $59.9K | 2025-01-22 |
| 2025-02-18 | S, sale reported on Form 4 | 6,182 | $517.1K | 2025-02-19 |
| 2025-02-18 | S, sale reported on Form 4 | 1,818 | $153.8K | 2025-02-19 |
| 2026-06-18 | S, sale reported on Form 4 | 10,000 | $530.0K | 2026-06-18 |
| 2026-07-06 | S, sale reported on Form 4 | 7,913 | $452.3K | 2026-07-06 |
| 2026-07-06 | S, sale reported on Form 4 | 2,087 | $120.6K | 2026-07-06 |
| 2026-08-03 | S, sale reported on Form 4 | 6,956 | $374.0K | 2026-08-05 |
| 2026-08-03 | S, sale reported on Form 4 | 3,044 | $164.9K | 2026-08-05 |
Caribou Biosciences, Inc. (CRBU)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
MTCR
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1230724) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms